{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T11:54:44Z","timestamp":1765886084279},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Governmental Funding of Clinical Research within the National Health Services","award":["Swedish research council nr: 523-2010-520"],"award-info":[{"award-number":["Swedish research council nr: 523-2010-520"]}]},{"name":"Swedish Parkinson\u00b4s foundation"},{"name":"Kockska foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Geriatr"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12877-018-0740-4","type":"journal-article","created":{"date-parts":[[2018,2,17]],"date-time":"2018-02-17T04:18:38Z","timestamp":1518841118000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Psychotropic and anti-dementia treatment in elderly persons with clinical signs of dementia with Lewy bodies: a cross-sectional study in 40 nursing homes in Sweden"],"prefix":"10.1186","volume":"18","author":[{"given":"Iris","family":"Zahirovic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gustav","family":"Torisson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carina","family":"Wattmo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabet","family":"Londos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,2,17]]},"reference":[{"issue":"9503","key":"740_CR1","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1016\/S0140-6736(05)67889-0","volume":"366","author":"CP Ferri","year":"2005","unstructured":"Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M, et al. Global prevalence of dementia: a Delphi consensus study. Lancet. 2005;366(9503):2112\u20137.","journal-title":"Lancet"},{"issue":"1","key":"740_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jalz.2012.11.006","volume":"9","author":"A Wimo","year":"2013","unstructured":"Wimo A, Jonsson L, Bond J, Prince M, Winblad B, Alzheimer DI. The worldwide economic impact of dementia 2010. Alzheimer's dement. 2013;9(1):1\u201311. e3","journal-title":"Alzheimer's dement"},{"issue":"39","key":"740_CR3","first-page":"684","volume":"107","author":"B Mollenhauer","year":"2010","unstructured":"Mollenhauer B, Forstl H, Deuschl G, Storch A, Oertel W, Lewy TC. Body and parkinsonian dementia: common, but often misdiagnosed conditions. Deutsches Arzteblatt international. 2010;107(39):684\u201391.","journal-title":"Deutsches Arzteblatt international"},{"issue":"6","key":"740_CR4","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1093\/ageing\/afi190","volume":"34","author":"J Zaccai","year":"2005","unstructured":"Zaccai J, McCracken C, Brayne C. A systematic review of prevalence and incidence studies of dementia with Lewy bodies. Age Ageing. 2005;34(6):561\u20136.","journal-title":"Age Ageing"},{"issue":"7","key":"740_CR5","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1097\/JGP.0b013e318167ae76","volume":"16","author":"G Selbaek","year":"2008","unstructured":"Selbaek G, Kirkevold O, Engedal K. The course of psychiatric and behavioral symptoms and the use of psychotropic medication in patients with dementia in Norwegian nursing homes--a 12-month follow-up study. A J Geriatr Psychiatry. 2008;16(7):528\u201336.","journal-title":"A J Geriatr Psychiatry"},{"issue":"2","key":"740_CR6","doi-asserted-by":"publisher","first-page":"117","DOI":"10.2174\/157015908784533860","volume":"6","author":"R Liperoti","year":"2008","unstructured":"Liperoti R, Pedone C, Corsonello A. Antipsychotics for the treatment of behavioral and psychological symptoms of dementia (BPSD). Curr Neuropharmacol. 2008;6(2):117\u201324.","journal-title":"Curr Neuropharmacol"},{"issue":"12","key":"740_CR7","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","volume":"65","author":"IG McKeith","year":"2005","unstructured":"McKeith IG, Dickson DW, Lowe J, Emre M, O'Brien JT, Feldman H, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB consortium. Neurology. 2005;65(12):1863\u201372.","journal-title":"Neurology"},{"issue":"1","key":"740_CR8","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S1474-4422(03)00619-7","volume":"3","author":"I McKeith","year":"2004","unstructured":"McKeith I, Mintzer J, Aarsland D, Burn D, Chiu H, Cohen-Mansfield J, et al. Dementia with Lewy bodies. The Lancet Neurology. 2004;3(1):19\u201328.","journal-title":"The Lancet Neurology."},{"issue":"1","key":"740_CR9","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","volume":"89","author":"IG McKeith","year":"2017","unstructured":"McKeith IG, et al. Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB consortium. Neurology 2017;89(1):88\u2013100.","journal-title":"Neurology"},{"issue":"3","key":"740_CR10","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/j.1750-3639.2008.00169.x","volume":"18","author":"K Fujimi","year":"2008","unstructured":"Fujimi K, Sasaki K, Noda K, Wakisaka Y, Tanizaki Y, Matsui Y, et al. Clinicopathological outline of dementia with Lewy bodies applying the revised criteria: the Hisayama study. Brain Pathol. 2008;18(3):317\u201325.","journal-title":"Brain Pathol"},{"issue":"6","key":"740_CR11","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/nrn1926","volume":"7","author":"C Ballard","year":"2006","unstructured":"Ballard C, Howard R. Neuroleptic drugs in dementia: benefits and harm. Nat Rev Neurosci. 2006;7(6):492\u2013500.","journal-title":"Nat Rev Neurosci"},{"issue":"22","key":"740_CR12","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1056\/NEJMoa052827","volume":"353","author":"PS Wang","year":"2005","unstructured":"Wang PS, Schneeweiss S, Avorn J, Fischer MA, Mogun H, Solomon DH, et al. Risk of death in elderly users of conventional vs. atypical antipsychotic medications. N Engl J Med. 2005;353(22):2335\u201341.","journal-title":"N Engl J Med"},{"issue":"4","key":"740_CR13","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.jagp.2013.06.007","volume":"22","author":"EM Langballe","year":"2014","unstructured":"Langballe EM, Engdahl B, Nordeng H, Ballard C, Aarsland D, Selb\u00e6k G. Short- and long-term mortality risk associated with the use of antipsychotics among 26,940 dementia outpatients: a population-based study. Am J Geriatr Psychiatry. 2014;22(4):321\u201331.","journal-title":"Am J Geriatr Psychiatry"},{"issue":"4","key":"740_CR14","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1002\/gps.4015","volume":"29","author":"A Rongve","year":"2014","unstructured":"Rongve A, Vossius C, Nore S, Testad I, Aarsland D. Time until nursing home admission in people with mild dementia: comparison of dementia with Lewy bodies and Alzheimer's dementia. International journal of geriatric psychiatry. 2014;29(4):392\u20138.","journal-title":"International journal of geriatric psychiatry"},{"issue":"11","key":"740_CR15","doi-asserted-by":"publisher","first-page":"775","DOI":"10.7326\/0003-4819-146-11-200706050-00006","volume":"146","author":"SS Gill","year":"2007","unstructured":"Gill SS, Bronskill SE, Normand SL, Anderson GM, Sykora K, Lam K, et al. Antipsychotic drug use and mortality in older adults with dementia. Ann Intern Med. 2007;146(11):775\u201386.","journal-title":"Ann Intern Med"},{"issue":"3","key":"740_CR16","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1097\/01.JGP.0000200589.01396.6d","volume":"14","author":"LS Schneider","year":"2006","unstructured":"Schneider LS, Dagerman K, Insel PS. Efficacy and Adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials. Am J Geriatr Psychiatry. 2006;14(3):191\u2013210.","journal-title":"Am J Geriatr Psychiatry."},{"issue":"7","key":"740_CR17","doi-asserted-by":"publisher","first-page":"511","DOI":"10.2165\/00002018-200225070-00005","volume":"25","author":"MM Swanberg","year":"2002","unstructured":"Swanberg MM, Cummings JL. Benefit-risk considerations in the treatment of dementia with Lewy bodies. Drug Saf. 2002;25(7):511\u201323.","journal-title":"Drug Saf"},{"issue":"6855","key":"740_CR18","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1136\/bmj.305.6855.673","volume":"305","author":"I McKeith","year":"1992","unstructured":"McKeith I, Fairbairn A, Perry R, Thompson P, Perry E. Neuroleptic sensitivity in patients with senile dementia of Lewy body type. BMJ. 1992;305(6855):673\u20138.","journal-title":"BMJ"},{"issue":"7","key":"740_CR19","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/S1474-4422(09)70146-2","volume":"8","author":"D Aarsland","year":"2009","unstructured":"Aarsland D, Ballard C, Walker Z, Bostrom F, Alves G, Kossakowski K, et al. Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial. The Lancet Neurology. 2009;8(7):613\u20138.","journal-title":"The Lancet Neurology."},{"key":"740_CR20","unstructured":"FDA: 2008 Information on Conventional Antipsychotics [Internet]. U.S. Food and Drug Administration. 6\/16\/2008."},{"key":"740_CR21","volume-title":"The usage of antipsychotic medication according to Swedish National Board of Health and Welfare \"Anv\u00e4ndning av antipsykotiska l\u00e4kemedel hos \u00e4ldre\"","author":"Welfare TSNBoHa","year":"2015","unstructured":"Welfare TSNBoHa. The usage of antipsychotic medication according to Swedish National Board of Health and Welfare \"Anv\u00e4ndning av antipsykotiska l\u00e4kemedel hos \u00e4ldre\". 2015."},{"key":"740_CR22","unstructured":"EMEA EMA. European Medicines Agency: CHMP assessment report on conventional antipsychotics. Procedure under Article 5(3) of Regulation (EC) No 726\/2004. 2004;590557\/2008."},{"issue":"5","key":"740_CR23","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1503\/cmaj.061250","volume":"176","author":"S Schneeweiss","year":"2007","unstructured":"Schneeweiss S, Setoguchi S, Brookhart A, Dormuth C, Wang PS. Risk of death associated with the use of conventional versus atypical antipsychotic drugs among elderly patients. CMAJ. 2007;176(5):627\u201332.","journal-title":"CMAJ"},{"issue":"7","key":"740_CR24","doi-asserted-by":"publisher","first-page":"e68976","DOI":"10.1371\/journal.pone.0068976","volume":"8","author":"B Guthrie","year":"2013","unstructured":"Guthrie B, Clark SA, Reynish EL, McCowan C, Morales DR. Differential impact of two risk communications on antipsychotic prescribing to people with dementia in Scotland: segmented regression time series analysis 2001-2011. PLoS One. 2013;8(7):e68976.","journal-title":"PLoS One"},{"issue":"9","key":"740_CR25","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1002\/gps.438","volume":"16","author":"MS Giron","year":"2001","unstructured":"Giron MS, Forsell Y, Bernsten C, Thorslund M, Winblad B, Fastbom J. Psychotropic drug use in elderly people with and without dementia. International journal of geriatric psychiatry. 2001;16(9):900\u20136.","journal-title":"International journal of geriatric psychiatry."},{"issue":"2","key":"740_CR26","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1001\/archgenpsychiatry.2010.200","volume":"68","author":"HC Kales","year":"2011","unstructured":"Kales HC, Zivin K, Kim HM, Valenstein M, Chiang C, Ignacio RV, et al. Trends in antipsychotic use in dementia 1999-2007. Arch Gen Psychiatry. 2011;68(2):190\u20137.","journal-title":"Arch Gen Psychiatry"},{"issue":"1","key":"740_CR27","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1080\/02813430600991980","volume":"25","author":"A Bergman","year":"2007","unstructured":"Bergman A, Olsson J, Carlsten A, Waern M, Fastbom J. Evaluation of the quality of drug therapy among elderly patients in nursing homes. Scand J Prim Health Care. 2007;25(1):9\u201314.","journal-title":"Scand J Prim Health Care"},{"issue":"3","key":"740_CR28","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.3233\/JAD-160485","volume":"54","author":"JK Zakarias","year":"2016","unstructured":"Zakarias JK, Jensen-Dahm C, Norgaard A, Stevnsborg L, Gasse C, Andersen BG, et al. Geographical variation in antipsychotic drug use in elderly patients with dementia: a Nationwide study. Journal of Alzheimer's disease: JAD. 2016;54(3):1183\u201392.","journal-title":"Journal of Alzheimer's disease: JAD"},{"issue":"8","key":"740_CR29","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.jamda.2016.03.017","volume":"17","author":"I Zahirovic","year":"2016","unstructured":"Zahirovic I, Wattmo C, Torisson G, Minthon L, Londos E. Prevalence of dementia with Lewy body symptoms: a cross-sectional study in 40 Swedish nursing homes. J Am Med Dir Assoc. 2016;17(8):706\u201311.","journal-title":"J Am Med Dir Assoc"},{"key":"740_CR30","unstructured":"The Swedish National Board of Health and Welfare. National Guidelines for Health and Social Care for demented elderly 2016\/Nationella riktlinjer f\u00f6r v\u00e5rd och omsorg vid demenssjukdom. 2016."},{"key":"740_CR31","unstructured":"Lewy Body Dementia Association. Lewy Body Dementia Diagnostic Symptoms. \n                    https:\/\/www.lbda.org\/content\/symptoms\n                    \n                  , 2016."},{"issue":"Web Server","key":"740_CR32","doi-asserted-by":"publisher","first-page":"W55","DOI":"10.1093\/nar\/gkn307","volume":"36","author":"M Dunkel","year":"2008","unstructured":"Dunkel M, Gunther S, Ahmed J, Wittig B, Preissner R. SuperPred: drug classification and target prediction. Nucleic Acids Res. 2008;36(Web Server):W55\u20139.","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"740_CR33","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1159\/000165917","volume":"26","author":"D Aarsland","year":"2008","unstructured":"Aarsland D, Rongve A, Nore SP, Skogseth R, Skulstad S, Ehrt U, et al. Frequency and case identification of dementia with Lewy bodies using the revised consensus criteria. Dement Geriatr Cogn Disord. 2008;26(5):445\u201352.","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"2","key":"740_CR34","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1097\/WAD.0b013e318065c4a9","volume":"21","author":"F Bostrom","year":"2007","unstructured":"Bostrom F, Jonsson L, Minthon L, Londos E. Patients with dementia with lewy bodies have more impaired quality of life than patients with Alzheimer disease. Alzheimer Dis Assoc Disord. 2007;21(2):150\u20134.","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"4","key":"740_CR35","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1177\/089198870201500402","volume":"15","author":"JL Heidebrink","year":"2002","unstructured":"Heidebrink JL. Is dementia with Lewy bodies the second most common cause of dementia? J Geriatr Psychiatry Neurol. 2002;15(4):182\u20137.","journal-title":"J Geriatr Psychiatry Neurol"},{"issue":"12","key":"740_CR36","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/S1474-4422(15)00258-6","volume":"14","author":"R Howard","year":"2015","unstructured":"Howard R, McShane R, Lindesay J, Ritchie C, Baldwin A, Barber R, et al. Nursing home placement in the donepezil and Memantine in moderate to severe Alzheimer's disease (DOMINO-AD) trial: secondary and post-hoc analyses. The Lancet Neurology. 2015;14(12):1171\u201381.","journal-title":"The Lancet Neurology"},{"issue":"10","key":"740_CR37","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1176\/appi.ajp.2007.06101710","volume":"164","author":"HC Kales","year":"2007","unstructured":"Kales HC, Valenstein M, Kim HM, McCarthy JF, Ganoczy D, Cunningham F, et al. Mortality risk in patients with dementia treated with antipsychotics versus other psychiatric medications. Am J Psychiatry. 2007;164(10):1568\u201376. quiz 623","journal-title":"Am J Psychiatry"},{"issue":"8","key":"740_CR38","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1176\/appi.ajp.2015.14121582","volume":"172","author":"C Stinton","year":"2015","unstructured":"Stinton C, McKeith I, Taylor JP, Lafortune L, Mioshi E, Mak E, et al. Pharmacological Management of Lewy Body Dementia: a systematic review and meta-analysis. Am J Psychiatry. 2015;172(8):731\u201342.","journal-title":"Am J Psychiatry"},{"issue":"2","key":"740_CR39","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s00415-005-0943-4","volume":"253","author":"T Prohorov","year":"2006","unstructured":"Prohorov T, Klein C, Miniovitz A, Dobronevsky E, Rabey JM. The effect of quetiapine in psychotic parkinsonian patients with and without dementia. An open-labeled study utilizing a structured interview. J Neurol. 2006;253(2):171\u20135.","journal-title":"J Neurol"},{"issue":"17","key":"740_CR40","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1212\/01.wnl.0000260060.60870.89","volume":"68","author":"R Kurlan","year":"2007","unstructured":"Kurlan R, Cummings J, Raman R, Thal L. Alzheimer's disease cooperative study G. Quetiapine for agitation or psychosis in patients with dementia and parkinsonism. Neurology. 2007;68(17):1356\u201363.","journal-title":"Neurology"},{"issue":"8","key":"740_CR41","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1176\/appi.ajp.2011.08121844","volume":"168","author":"CL Vigen","year":"2011","unstructured":"Vigen CL, Mack WJ, Keefe RS, Sano M, Sultzer DL, Stroup TS, et al. Cognitive effects of atypical antipsychotic medications in patients with Alzheimer's disease: outcomes from CATIE-AD. Am J Psychiatry. 2011;168(8):831\u20139.","journal-title":"Am J Psychiatry"},{"issue":"12","key":"740_CR42","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1016\/j.jagp.2015.07.001","volume":"23","author":"A Vasudev","year":"2015","unstructured":"Vasudev A, Shariff SZ, Liu K, Burhan AM, Herrmann N, Leonard S, et al. Trends in psychotropic dispensing among older adults with dementia living in long-term care facilities: 2004-2013. Am J Geriatr Psychiatry. 2015;23(12):1259\u201369.","journal-title":"Am J Geriatr Psychiatry."},{"key":"740_CR43","unstructured":"Agency MP. L\u00e4kemedelsbehandling och bem\u00f6tande vid Beteendem\u00e4ssiga och Psykiatriska Symptom vid Demenssjukdom-BPSD. 2008;5:15\u201324."},{"issue":"4","key":"740_CR44","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.amjopharm.2008.10.002","volume":"6","author":"P Kamble","year":"2008","unstructured":"Kamble P, Chen H, Sherer J, Aparasu RR. Antipsychotic drug use among elderly nursing home residents in the United States. Am J Geriatr Pharmacother. 2008;6(4):187\u201397.","journal-title":"Am J Geriatr Pharmacother"},{"issue":"9","key":"740_CR45","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1017\/S1041610211000445","volume":"23","author":"J Snowdon","year":"2011","unstructured":"Snowdon J, Galanos D, Vaswani D. Patterns Of psychotropic medication use in nursing homes: surveys in Sydney, allowing comparisons over time and between countries. International psychogeriatrics \/ IPA. 2011;23(9):1520\u20135.","journal-title":"International psychogeriatrics \/ IPA"},{"issue":"4","key":"740_CR46","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/alzrt85","volume":"3","author":"C Wattmo","year":"2011","unstructured":"Wattmo C, Wallin AK, Londos E, Minthon L. Predictors of long-term cognitive outcome in Alzheimer's disease. Alzheimers Res Ther. 2011;3(4):23.","journal-title":"Alzheimers Res Ther"},{"issue":"3","key":"740_CR47","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1111\/cns.12484","volume":"22","author":"J Cummings","year":"2016","unstructured":"Cummings J, Lai TJ, Hemrungrojn S, Mohandas E, Yun Kim S, Nair G, et al. Role of donepezil in the Management of Neuropsychiatric Symptoms in Alzheimer's disease and dementia with Lewy bodies. CNS neuroscience & therapeutics. 2016;22(3):159\u201366.","journal-title":"CNS neuroscience & therapeutics"}],"container-title":["BMC Geriatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-018-0740-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,17]],"date-time":"2019-02-17T02:28:55Z","timestamp":1550370535000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgeriatr.biomedcentral.com\/articles\/10.1186\/s12877-018-0740-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,17]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["740"],"URL":"https:\/\/doi.org\/10.1186\/s12877-018-0740-4","relation":{},"ISSN":["1471-2318"],"issn-type":[{"value":"1471-2318","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,17]]},"assertion":[{"value":"23 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Informed consent forms were given to the head nurses at the 40 NHs; they thereafter collected oral informed consent from the residents and\/or their family members.If the resident lacked the capacity to consent himself\/herself because of fragility the family member and\/or trustee made this decision together with the head nurse before inclusion in the study. The Regional Ethical Review Board in Lund approved this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"50"}}